• OPEN AN ACCOUNT
Indian Indices
Sensex
82,269.78 -296.59
( -0.36%)
Global Indices
Nasdaq
48,928.31 -164.26
(-0.33%)
Dow Jones
6,963.16 -26.85
(-0.38%)
Hang Seng
53,392.10 16.50
(0.03%)
Nikkei 225
10,214.90 43.14
(0.42%)
Forex
USD-INR
91.92 0.08
(0.09%)
EUR-INR
109.97 0.03
(0.03%)
GBP-INR
126.94 0.27
(0.21%)
JPY-INR
0.60 0.00
(0.00%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
99.2482659
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
81.88
382693.93
EPS(TTM)
Face Value()
Div & Yield %
19.48
1
1
 

WPIL jumps after South Africa arm wins Rs 426-cr MCWAP2 project contract
Nov 18,2025

The subsidiary will carry out complete electro-mechanical and instrumentation works for the Trans Caledon Tunnel Authority’s MCWAP2 Project in South Africa.

The total value of the contract stands at 821 million Rand (Rs 426 crore), with a project execution timeline of 48 months, the company said.

WPIL clarified that the contract does not fall under related-party transactions.

WPIL is engaged in designing, developing, manufacturing, erecting, commissioning and servicing of pumps & pumping systems.

The company’s consolidated net profit tanked 31.9% to Rs 41.02 crore on 13.2% decline in revenue from operations to Rs 426.02 crore in Q2 FY26 over Q2 FY25.